Added to YB: 2025-07-28
Pitch date: 2025-07-24
FBIO [bullish]
Fortress Biotech, Inc.
+51.03%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Fortress Biotech, Inc., a biopharmaceutical company, engages in the development and commercialization of biopharmaceutical products.
Market Cap
$58.3M
Pitch Price
$1.94
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.64
P/E
-0.90
EV/Sales
0.89
Sector
Biotechnology
Category
special_situation
Show full summary:
Fortress Biotech - New all-time high in $FBIOP shares & size in the stock portfolio
FBIO (added to position): Still bullish despite CAEL-101 setback. Reinstated dividend likely by Mar 2026 via: 1) Strong EMROSI sales 2) CUTX-101 FDA approval/PRV or 3) CAEL-101 P3 success. Journey near sales targets. Multiple backup plans incl. Dotinurad & Triplex. Added to FBIOP position after initial sale.
Read full article (8 min)